Dr. Fram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Immunogen, Inc.
128 Sidney St
Cambridge, MA 02138Phone+1 617-995-4909
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1976 - 1979
Harvard Medical SchoolClass of 1976
Certifications & Licensure
MA State Medical License 1979 - 2025
RI State Medical License 1997 - 2000
NJ State Medical License 1996 - 1997
MD State Medical License 1993 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1998
Publications & Presentations
PubMed
- A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations.Kiyotaka Yoh, Koichi Azuma, Hidetoshi Hayashi, Makoto Nishio, Kenichi Chikamori
International Journal of Clinical Oncology. 2024-10-01 - 6 citationsMobocertinib: Mechanism of action, clinical, and translational science.Michael J Hanley, D Ross Camidge, Robert J Fram, Neeraj Gupta
Clinical and Translational Science. 2024-03-01 - 58 citationsPevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.Lionel Adès, Larisa Girshova, Vadim A Doronin, María Díez-Campelo, David Valcárcel
Blood Advances. 2022-09-13
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
